Publicaciones en colaboración con investigadores/as de National Institutes of Health (3)

2017

  1. Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

    The Lancet, Vol. 390, Núm. 10103, pp. 1664-1675

2016

  1. A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease

    Science Translational Medicine, Vol. 8, Núm. 341

2014

  1. Perceptual decision-making in patients with Parkinson's disease

    Journal of Psychopharmacology, Vol. 28, Núm. 12, pp. 1149-1154